Bill
HR 124
The Byron Nash Renal Medullary Carcinoma Awareness Act boosts awareness, early diagnosis, and research funding for this rare kidney cancer, benefiting patients and healthcare providers.
The Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 aims to raise awareness about renal medullary carcinoma (RMC), a rare and aggressive form of kidney cancer primarily affecting young individuals, particularly those of African descent. The bill seeks to enhance public knowledge, improve early diagnosis, and promote research funding for this under-recognized disease.
While the specific text of the bill has not been detailed in the provided information, typical provisions in awareness acts may include:
Awareness Campaigns: Establishing initiatives to educate the public and healthcare professionals about RMC, its symptoms, and the importance of early detection.
Research Funding: Allocating federal resources to support research initiatives aimed at understanding the causes, treatment options, and potential cures for renal medullary carcinoma.
Collaboration with Health Organizations: Encouraging partnerships with relevant health organizations and advocacy groups to disseminate information and resources related to RMC.
The bill is expected to impact several groups, including:
Patients and Families: Individuals diagnosed with renal medullary carcinoma and their families will benefit from increased awareness and potential early detection strategies.
Healthcare Providers: Medical professionals will receive updated information and training on recognizing and treating RMC, which may lead to improved patient outcomes.
Researchers and Institutions: Increased funding and focus on RMC may provide researchers with the necessary resources to advance studies in this area.
Introduced: The bill was introduced in the House on January 3, 2025.
Referred to Committee: On the same day, it was referred to the House Committee on Energy and Commerce for further consideration.
As the bill progresses through the legislative process, it will undergo discussions, potential amendments, and votes within the committee and the broader House of Representatives.
The Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 represents a significant step towards addressing the challenges associated with renal medullary carcinoma. By promoting awareness and research, the bill aims to improve outcomes for those affected by this rare cancer and ensure that healthcare providers are better equipped to recognize and treat it.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
